For Immediate Release: July 06, 2023 Today, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimers Disease, to traditional appro… [+6044 chars]Read More
FDA Converts Novel Alzheimers Disease Treatment to Traditional Approval FDAgov
